Double-blind, Placebo-controlled Clinical Study to Evaluate the Efficacy, Safety and Tolerability of a Fixed Dose of Remegal as Adjunctive Therapy in Patients With Partial Seizures
Latest Information Update: 14 Jan 2020
At a glance
- Drugs Beprodone (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- Sponsors Valexfarm
- 10 May 2017 Status changed from recruiting to completed.
- 14 Jan 2013 New trial record